• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肾损伤(AKI)在接受侵入性治疗的 ACS 患者中的预防和管理。

Prevention and Management of AKI in ACS Patients Undergoing Invasive Treatments.

机构信息

Department of Internal Medicine, Division of Cardiology, Medical Branch, University of Texas, 301 University Blvd, Galveston, TX, 77550, USA.

出版信息

Curr Cardiol Rep. 2022 Oct;24(10):1299-1307. doi: 10.1007/s11886-022-01742-0. Epub 2022 Aug 4.

DOI:10.1007/s11886-022-01742-0
PMID:35925513
Abstract

PURPOSE OF REVIEW

Management of patients presenting with acute coronary syndrome (ACS) includes invasive procedures that may increase the risk of acute kidney injury (AKI). AKI adversely affects the outcomes of such procedures and complicates the management of ACS. We have summarized several strategies for the prevention and management of AKI in this critical patient group including in the pre-procedural, intraprocedural, and post-procedural settings.

RECENT FINDINGS

Definitive prevention and management strategies for AKI in patients presenting with ACS requiring invasive management can be confounded by the variation in data outcomes. Pre-procedural hydration with normal saline when accounting for time to catheterization, radial artery access, contrast stewardship, and close monitoring of renal function after catheterization should be implemented.

摘要

目的综述

急性冠状动脉综合征(ACS)患者的治疗包括可能增加急性肾损伤(AKI)风险的有创性操作。AKI 会对这些操作的结果产生不良影响,并使 ACS 的治疗复杂化。我们总结了该类高危患者群体的 AKI 预防和处理策略,包括术前、术中和术后。

最新发现

由于数据结果的差异,需要进行有创性治疗的 ACS 患者 AKI 的明确预防和处理策略可能会变得复杂。术前应考虑到置管时间、桡动脉入路、对比剂管理以及置管后肾功能的密切监测,用生理盐水进行水化治疗。

相似文献

1
Prevention and Management of AKI in ACS Patients Undergoing Invasive Treatments.急性肾损伤(AKI)在接受侵入性治疗的 ACS 患者中的预防和管理。
Curr Cardiol Rep. 2022 Oct;24(10):1299-1307. doi: 10.1007/s11886-022-01742-0. Epub 2022 Aug 4.
2
Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.经皮冠状动脉介入治疗后急性肾损伤:AKI-MATRIX(通过桡动脉穿刺部位及血管造影X系统全面应用减少急性肾损伤不良出血事件)子研究的原理
Catheter Cardiovasc Interv. 2015 Nov;86(5):950-7. doi: 10.1002/ccd.25932. Epub 2015 Apr 9.
3
Radial vs femoral access for the prevention of acute kidney injury (AKI) after coronary angiography or intervention: A systematic review and meta-analysis.经桡动脉与股动脉入路对冠状动脉造影或介入术后急性肾损伤(AKI)预防的系统评价与荟萃分析。
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E518-E526. doi: 10.1002/ccd.27903. Epub 2018 Sep 23.
4
Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).急性冠状动脉综合征中早期大剂量瑞舒伐他汀预防造影剂肾病:来自 PRATO-ACS 研究的结果(瑞舒伐他汀和抗血小板治疗对急性冠状动脉综合征患者造影剂诱导的急性肾损伤和心肌损伤的保护作用)。
J Am Coll Cardiol. 2014;63(1):71-9. doi: 10.1016/j.jacc.2013.04.105. Epub 2013 Sep 26.
5
Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.径向入路可预防心导管检查术后对比剂诱导的肾病。
Clin Res Cardiol. 2018 Feb;107(2):148-157. doi: 10.1007/s00392-017-1166-2. Epub 2017 Sep 22.
6
Avoiding the emergence of contrast-induced acute kidney injury in acute coronary syndrome: routine hydration treatment.避免急性冠状动脉综合征中对比剂诱导的急性肾损伤的发生:常规水化治疗
Coron Artery Dis. 2021 Aug 1;32(5):397-402. doi: 10.1097/MCA.0000000000000966.
7
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial.急性冠状动脉综合征患者经介入治疗时,桡动脉或股动脉入路后急性肾损伤和出血事件与死亡率的关系:一项随机临床试验的二次分析。
Eur Heart J. 2019 Apr 14;40(15):1226-1232. doi: 10.1093/eurheartj/ehy860.
8
Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.降钙素原作为接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者造影剂诱导的急性肾损伤的早期预测指标。
Angiology. 2015 Nov;66(10):957-63. doi: 10.1177/0003319715572218. Epub 2015 Feb 16.
9
Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.经皮冠状动脉介入治疗中对比剂相关急性肾损伤预防的变化:来自退伍军人事务临床评估、报告和跟踪(CART)计划的见解。
BMC Nephrol. 2020 Apr 28;21(1):150. doi: 10.1186/s12882-020-01802-z.
10
Impact of concomitant peripheral artery disease on contrast-induced acute kidney injury and mortality in patients with acute coronary syndrome after percutaneous coronary intervention.经皮冠状动脉介入治疗后,合并外周动脉疾病对急性冠状动脉综合征患者造影剂诱导的急性肾损伤及死亡率的影响。
Heart Vessels. 2020 Oct;35(10):1360-1367. doi: 10.1007/s00380-020-01614-z. Epub 2020 Apr 27.

引用本文的文献

1
Predictive modeling for acute kidney injury after percutaneous coronary intervention in patients with acute coronary syndrome: a machine learning approach.急性冠状动脉综合征患者经皮冠状动脉介入治疗后急性肾损伤的预测模型:机器学习方法。
Eur J Med Res. 2024 Jan 24;29(1):76. doi: 10.1186/s40001-024-01675-0.

本文引用的文献

1
Evidence-Based Practices in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association.心脏导管实验室中的循证实践:美国心脏协会的科学声明。
Circulation. 2021 Aug 3;144(5):e107-e119. doi: 10.1161/CIR.0000000000000996. Epub 2021 Jun 30.
2
Trials and tribulations of diagnosing and preventing contrast-induced acute kidney injury.诊断和预防造影剂诱发的急性肾损伤的试验与磨难
J Thorac Cardiovasc Surg. 2021 Nov;162(5):1581-1586. doi: 10.1016/j.jtcvs.2020.06.147. Epub 2020 Jul 31.
3
Post-operative renal failure management in mechanical circulatory support patients.
机械循环支持患者术后肾衰竭的管理
Ann Transl Med. 2020 Jul;8(13):833. doi: 10.21037/atm-20-1172.
4
Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.Impella 辅助支持与高危经皮冠状动脉介入治疗期间的急性肾损伤:全球 cVAD 肾脏保护研究。
Catheter Cardiovasc Interv. 2020 May 1;95(6):1111-1121. doi: 10.1002/ccd.28400. Epub 2019 Jul 29.
5
Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis.等渗与低渗对比剂对糖尿病患者对比剂诱导急性肾损伤发生率影响的比较:系统评价和荟萃分析。
Cancer Imaging. 2019 Jun 18;19(1):38. doi: 10.1186/s40644-019-0224-6.
6
Contrast-Associated Acute Kidney Injury.对比剂相关急性肾损伤
N Engl J Med. 2019 May 30;380(22):2146-2155. doi: 10.1056/NEJMra1805256.
7
The use of ultra low contrast volume during percutaneous coronary intervention and risk of acute kidney injury: How low can we go?经皮冠状动脉介入治疗中使用超低对比剂容量与急性肾损伤风险:我们能低到什么程度?
Catheter Cardiovasc Interv. 2019 Feb 1;93(2):231-232. doi: 10.1002/ccd.28090.
8
Association of Statewide Certificate of Need Regulations With Percutaneous Coronary Intervention Appropriateness and Outcomes.全州需求证书监管规定与经皮冠状动脉介入术适宜性和结局的关联。
J Am Heart Assoc. 2019 Jan 22;8(2):e010373. doi: 10.1161/JAHA.118.010373.
9
Meta-Analysis and Trial Sequential Analysis Comparing Percutaneous Ventricular Assist Devices Versus Intra-Aortic Balloon Pump During High-Risk Percutaneous Coronary Intervention or Cardiogenic Shock.Meta 分析和试验序贯分析比较高危经皮冠状动脉介入治疗或心源性休克期间经皮心室辅助装置与主动脉内球囊反搏的效果。
Am J Cardiol. 2018 Oct 15;122(8):1330-1338. doi: 10.1016/j.amjcard.2018.07.011. Epub 2018 Jul 24.
10
Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions.在接受经皮冠状动脉介入治疗的患者中,与超低对比量相关的当代应用和结局。
Catheter Cardiovasc Interv. 2019 Feb 1;93(2):222-230. doi: 10.1002/ccd.27819. Epub 2018 Aug 25.